Although the dual role of FSP1 in cell death pathways suggests that FSP1 exhibits great potential for AML-M5 therapy, whether similar effects of FSP1 exist in other forms of leukemia or solid tumors still need to be explored. This evidence concerns the gene AIFM2 and leukemia.